Fludarabine phosphate as an active and well tolerated salvage therapy in an elderly heavily pretreated Hodgkin's disease patient: A case report

Tumori

Volumn 85, Issue 4, 1999, Pages 288-289

  Bordonaro, Roberto ^a,b   Ferraù, Francesco ^a   Giuffrida, Dario ^a   Calì, Stefania ^a   Priolo, Domenico ^a   Colina, Paolo ^a   Ursino, Maria ^a   Failla, Giuseppe ^a  

^a S Luigi S Currò Hospital   (Italy)

^b Divisione di Oncologia Medica   (Italy)

Author keywords

Elderly; Fludarabine phosphate; Hodgkin's disease

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE PHOSPHATE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

AGED; ARTICLE; BONE DISEASE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; FEMALE; HODGKIN DISEASE; HUMAN; SALVAGE THERAPY;

EID: 0032845414     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169908500415     Document Type: Article

References (10)

1. Cheson B.D.: New chemotherapeutic agents for the treatment of low-grade non-Hodgkin's lymphomas. Semin. Oncol., 20 (Suppl. 5): 96-110, 1993.
2. Cheson B.D.: Infectious and immunosuppressive complications of purine analog therapy. J. Clin. Oncol., 13: 2431-2448, 1995.
3. Devizzi L., Santoro A., Bonfante V., Viviani S., Balzarini L., Valagussa P., Bonadonna G.: Vinorelbine. An active drug for the management of patients with heavily pretreated Hodgkin's disease. Ann. Oncol., 5: 817-820, 1994.
4. Devizzi L., Santoro A., Bonfante V., Viviani S., Bonadonna G.: Vinorelbine: a new promising drug in Hodgkin's disease. Leuk. Lymph., 22: 409-414, 1996.
5. Grever M., Leiby J., Kraut E., Metz E., Neidhart J., Balcerzak S., Malspeis L.:A comprehensive phase I and II clinical investigation of fludarabine phosphate. Semin. Oncol., 17 (5 Suppl. 8): 39-48, 1990.
6. Kay A., Saven A., Carrera C.J., Carson D.A., Thurston D., Beutler E., Piro L.D.: 2-chlorodeoxyadenosine treatment of low-grade lymphomas. J. Clin. Oncol., 10: 371-377, 1992.
7. Longo D.L., Young R.C., Wasley M., Hubbard S.M., Duffey P.L., Jaffe E.S., De Vita V.T. Jr: Twenty years of MOPP therapy for Hodgkin's disease. J. Clin. Oncol., 4: 1295-1306, 1986.
8. Pott-Hoeck C., Hiddemann W.: Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias. Ann. Oncol., 6: 421-433, 1995.
9. Tallman M.S., Hakimian D.: Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders. Blood, 86: 2463-2474, 1995.
10. Tesch H., Santoro A., Fiedler F., Bonadonna G., Bredenfeld H., Oliva C., Buksmaui S., Sieber M., Diehl V.: Phase II study of gemcitabine in pretreated Hodgkin's disease: results of a multicenter study. Proc. ASH, 1997, abs.1514 (333-III).